Skip to main content

Resistance of neoplasms to immunological destruction: role of a macrophage chemotaxis inhibitor.

Publication ,  Journal Article
Pasternack, GR; Snyderman, R; Pike, MC; Johnson, RJ; Shin, HS
Published in: J Exp Med
July 1, 1978

Several tissue culture lines of 6C3HED, a murine lymphoma, were more susceptible to immunologic destruction in vivo than the highly virulent 6C3HED line maintained by serial intramuscular transplantation. The attenuated tissue culture cells were rejected by normal syngeneic recipients, but thymectomized mice were unable to reject attenuated cells. In such mice, the growth rate of attenuated cells was equivalent to the growth rate of virulent cells in normal syngeneic mice. The increased susceptibility of attenuated cells to destruction by syngeneic hosts was shown to correlate with decreased production by the tumor cells of a macrophage chemotaxis inhibitor, and not with altered antigen density. In addition, when inhibitor isolated from virulent cells was administered to mice challenged with attenuated cells, the latter cells became virulent in vivo. When attenuated and virulent cells were administered simultaneously in the same host, the attenuated cells were able to develop into progressively growing tumors. The data suggest that the successful growth of neoplastic cells in normal may require tumor cells to produce factors which subvert the ability of the host to mobilize macrophages rapidly at the tumor site.

Duke Scholars

Published In

J Exp Med

DOI

ISSN

0022-1007

Publication Date

July 1, 1978

Volume

148

Issue

1

Start / End Page

93 / 102

Location

United States

Related Subject Headings

  • Virulence
  • Thymus Gland
  • Neoplasms, Experimental
  • Mice
  • Male
  • Macrophages
  • Macrophage Migration-Inhibitory Factors
  • Lymphoma
  • Immunology
  • Chemotaxis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pasternack, G. R., Snyderman, R., Pike, M. C., Johnson, R. J., & Shin, H. S. (1978). Resistance of neoplasms to immunological destruction: role of a macrophage chemotaxis inhibitor. J Exp Med, 148(1), 93–102. https://doi.org/10.1084/jem.148.1.93
Pasternack, G. R., R. Snyderman, M. C. Pike, R. J. Johnson, and H. S. Shin. “Resistance of neoplasms to immunological destruction: role of a macrophage chemotaxis inhibitor.J Exp Med 148, no. 1 (July 1, 1978): 93–102. https://doi.org/10.1084/jem.148.1.93.
Pasternack GR, Snyderman R, Pike MC, Johnson RJ, Shin HS. Resistance of neoplasms to immunological destruction: role of a macrophage chemotaxis inhibitor. J Exp Med. 1978 Jul 1;148(1):93–102.
Pasternack, G. R., et al. “Resistance of neoplasms to immunological destruction: role of a macrophage chemotaxis inhibitor.J Exp Med, vol. 148, no. 1, July 1978, pp. 93–102. Pubmed, doi:10.1084/jem.148.1.93.
Pasternack GR, Snyderman R, Pike MC, Johnson RJ, Shin HS. Resistance of neoplasms to immunological destruction: role of a macrophage chemotaxis inhibitor. J Exp Med. 1978 Jul 1;148(1):93–102.

Published In

J Exp Med

DOI

ISSN

0022-1007

Publication Date

July 1, 1978

Volume

148

Issue

1

Start / End Page

93 / 102

Location

United States

Related Subject Headings

  • Virulence
  • Thymus Gland
  • Neoplasms, Experimental
  • Mice
  • Male
  • Macrophages
  • Macrophage Migration-Inhibitory Factors
  • Lymphoma
  • Immunology
  • Chemotaxis